Archive | November, 2009

ImmunoGen’s Second License to Amgen (IMGN, AMGN)

20 November 2009 – 7:45 am PST

Comments Off

ImmunoGen’s Second License to Amgen (IMGN, AMGN)

ImmunoGen, Inc. (NASDAQ:IMGN) has announced that Amgen, Inc. (NASDAQ:AMGN)Inc has licensed the exclusive right to use ImmunoGen’s maytansinoid Targeted Antibody Payload (TAP) technology for the development of anticancer therapeutics to an undisclosed target.

Continue reading...

CombinatoRx & Neuromed Merger at risk? (NASDAQ:CRXX)

20 November 2009 – 7:30 am PST

View Comments

CombinatoRx & Neuromed Merger at risk? (NASDAQ:CRXX)

Neuromed and CombinatoRx, Incorporated (NASDAQ:CRXX)has agreedto sign a definitive merger agreementvalued $28.8 million USD on 30thJune, 2009 according to a news published by the RTT News.

Continue reading...

Sucampo Granted Marketing Authorization From FDA (NASDAQ:SCMP)

20 November 2009 – 6:50 am PST

Comments Off

Sucampo Granted Marketing Authorization From FDA (NASDAQ:SCMP)

Sucampo Pharma Europe Ltd, a subsidiary of Sucampo Pharmaceuticals Inc (NASDAQ:SCMP) has announced that Swissmedic has granted a marketing authorization for Amitiza 24 mcg gel capsules for the long term treatment of patients with chronic idiopathic constipation (CIC).

Continue reading...

Pay Day Loans: Life Saver or Death Trap?

20 November 2009 – 6:00 am PST

View Comments

Pay Day Loans: Life Saver or Death Trap?

Pay day loans may sound like the perfect solution when you have an emergency or just need some extra cash. It sounds easy: no credit check, no assets to pledge, and no waiting. But is a pay day loan a life saver or a death trap?

Continue reading...

Exelixis PI3K Interim Data (NASDAQ:EXEL)

18 November 2009 – 7:20 am PST

Comments Off

Exelixis PI3K Interim Data (NASDAQ:EXEL)

Exelixis, Inc (NASDAQ:EXEL) has announced and reported that the interim data from an ongoing Phase 1 dose-escalation trial of XL147 (SAR245408) in combination with paclitaxel and carboplatin in patients with advanced solid tumors have displayed positive results.

Continue reading...

Auto Based Loans for People With Poor Credit

18 November 2009 – 6:00 am PST

Comments Off

Auto Based Loans for People With Poor Credit

The poor economy, bad real estate conditions, and lackluster job market have forced many families into a precarious financial position. They can’t get a loan based on the value of their house because the house isn’t worth what it’s mortgaged for. Getting a better paying job isn’t an option at the moment. So if money [...]

Continue reading...

Bullish Technical Breakout Alert (OTC:SNBP)

17 November 2009 – 11:04 am PST

Comments Off

Bullish Technical Breakout Alert (OTC:SNBP)

Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/17/09 on Sinobiopharma Inc (OTC:SNBP) Inc. has initiated an independent bullish technical trading alert for 11/17/09 on Sinobiopharma, Inc. (OTC:SNBP.OB).

Continue reading...

Zevotek Receives 5 Star Reviews (OTC:ZVTK)

17 November 2009 – 11:02 am PST

View Comments

Zevotek Receives 5 Star Reviews (OTC:ZVTK)

In a recent article titled Zevotek Poised to Explode Like Spongetech Delivery Systems?, I discussed the explosive growth potential for Zevotek, Inc. (OTC:ZVTK) and compared its potential growth to Spongetech (OTC:SPNG). It is notable that the stock has nearly doubled within two trading days since the article was published.

Continue reading...

ArQule’s Drug Discovery Platform (NASDAQ:ARQL)

17 November 2009 – 8:00 am PST

Comments Off

ArQule’s Drug Discovery Platform (NASDAQ:ARQL)

ArQule Inc (NASDAQ:ARQL) has presented their data at the AACR-NCI-EORTC meeting in Boston which clearly demonstrates the capabilities of Company’s proprietary drug discovery platform to generate a class of small molecules that has significant therapeutic potential.

Continue reading...

Enzo Biochem Ready to Reveal EGS21 Data (NYSE:ENZ)

17 November 2009 – 7:30 am PST

Comments Off

Enzo Biochem Ready to Reveal EGS21 Data (NYSE:ENZ)

Enzo Biochem Inc (NYSE:ENZ) has announced that their Vice President of Corporate Development, David Goldberg will speak about Company’s extensive oral immune regulation platform at the Windhover TA Partnerships 2009 Conference which will be held in Boston on Wednesday, November 18, 2009.

Continue reading...